PRIOTHERA
Priothera is a clinical-stage company developing orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies. We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in these patients.
PRIOTHERA
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2020-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.priothera.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
49 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Investors List
Bpifrance
Bpifrance investment in Debt Financing - Priothera
European Investment Bank
European Investment Bank investment in Debt Financing - Priothera
Fountain Healthcare Partners
Fountain Healthcare Partners investment in Series A - Priothera
Earlybird Venture Capital
Earlybird Venture Capital investment in Series A - Priothera
Tekla Capital Management
Tekla Capital Management investment in Series A - Priothera
HealthCap
HealthCap investment in Series A - Priothera
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-25 | Priothera Appoints Elisabeth Kueenburg M.D., as Chief Medical Officer |
Official Site Inspections
http://www.priothera.com
- Host name: 217.194.223.243
- IP address: 217.194.223.243
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
